Nightstar Therapeutics plc: key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2018)
- -$36.9M
- Total Assets (FY2018)
- $180.0M
- Total Equity (FY2018)
- $165.6M
- Cash Flows from Operating Activities (FY2018)
- -$45.6M
Source: Nightstar Therapeutics plc 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
